Create Account

One Health helps you track and understand your health simply.

Create Account

One Health helps you track and understand your health simply.

Erythropoietin

Immunology & Autoimmune

EPOSerum erythropoietin

Review status

Currently under review

Pending specialist review and validation.

What it shows

Erythropoietin is a hormone made mainly by your kidneys that signals your bone marrow to produce red blood cells. The test measures how much erythropoietin is circulating in your blood at the time of the draw.

It is often ordered together with a complete blood count and other studies when your clinician is looking for the cause of anemia or an increased red blood cell count. Levels reflect how well your kidneys sense oxygen needs and how your marrow is being instructed to respond.

Why it matters

This test helps clarify why red blood cell levels are low or high. When anemia is present, it can show whether your body is making enough of this hormone or is already trying hard to stimulate red blood cell production but is limited by issues such as iron or vitamin deficiencies, inflammation, or bone marrow problems. When red blood cells are increased, the result can help distinguish body responses to low oxygen, medication effects, or a marrow disorder.

Results can guide next steps, such as replacing missing nutrients, addressing low oxygen states, evaluating for rare hormone‑producing tumors, or considering medicines that stimulate red blood cell production. It is commonly ordered for unexplained fatigue, shortness of breath, abnormal blood counts, or known kidney disease.

Understanding your results

An unexpectedly low erythropoietin level in the setting of anemia suggests the kidneys are not producing enough hormone. This is common in chronic kidney disease and can also occur with some marrow conditions. In contrast, a high level often reflects the body’s response to low oxygen, blood loss, or destruction of red blood cells, and may be seen with chronic lung disease, sleep apnea, smoking, or living at high altitude.

If the level is high when red blood cells are already elevated, your clinician may look for causes such as low oxygen, smoking, certain tumors, or medication use. A low level with increased red cells can point toward a bone marrow condition such as polycythemia vera. Your clinician will interpret your result alongside your symptoms, hemoglobin, reticulocyte count, iron studies, kidney tests, oxygen measurements, and sometimes genetic testing. Follow up may include treating reversible causes, repeating the test, or referral to a hematology or kidney specialist.

Reference ranges

2.5918.5 mIU/mL
All sexes
0 days – 150 years

Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.

Factors that could impact Erythropoietin

  • Recent blood transfusion

    Transfused red cells improve oxygen delivery and can temporarily suppress your body’s erythropoietin production, lowering the measured level.

  • Altitude, oxygen, and smoking

    Living at high altitude, chronic lung or heart disease, sleep apnea, or smoking can reduce oxygen levels and raise erythropoietin as a compensatory response.

  • Medications and supplements

    Erythropoiesis‑stimulating agents raise levels, while some drugs such as certain blood pressure medicines may lower them. Androgens and some performance‑enhancing practices can also affect results.

  • Kidney and inflammatory conditions

    Chronic kidney disease often causes inappropriately low erythropoietin. Systemic inflammation or infection can alter the body’s signaling and complicate interpretation.

  • Pregnancy

    Hormonal and blood volume changes during pregnancy can increase erythropoietin. Your clinician will interpret results in that context.

  • Timing and sample handling

    Mild day‑to‑day variation can occur. Proper collection and prompt processing help ensure a reliable measurement.

2026

References

  1. McGill University Health Centre. (2015, March 20). Erythropoietin (Task CD 695402). Laboratory reference ranges.
  2. Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group. (2012). KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney International Supplements, 2(4), 279–335.
  3. McMullin, M. F., Mead, A. J., Ali, S., Cargo, C., Chen, F., Ewing, J., Garg, M., Godfrey, A., Kulasekararaj, A., McLornan, D., Mesa, R., Sekhar, M., & Yeung, D. (2019). A guideline for the diagnosis, investigation and management of polycythaemia/erythrocytosis. British Journal of Haematology, 184(2), 161–175.